Developing Point-Guard, a cerebral embolic protection device meant to cover all three cerebral vessels during transcatheter procedures such as TAVR. It is working toward an FDA investigational device exemption after a feasibility study in Australia.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
No Spam. Unsubscribe anytime.